FLOREANI, ANNAROSA
 Distribuzione geografica
Continente #
NA - Nord America 21.263
EU - Europa 2.284
AS - Asia 2.191
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 5
SA - Sud America 5
Totale 25.761
Nazione #
US - Stati Uniti d'America 21.249
CN - Cina 1.082
SG - Singapore 853
IT - Italia 510
FI - Finlandia 446
DE - Germania 335
SE - Svezia 278
UA - Ucraina 230
FR - Francia 197
GB - Regno Unito 181
VN - Vietnam 161
IE - Irlanda 40
IN - India 33
HK - Hong Kong 24
NL - Olanda 21
JP - Giappone 12
ES - Italia 11
CA - Canada 9
PK - Pakistan 7
AU - Australia 6
BG - Bulgaria 6
EU - Europa 6
IQ - Iraq 6
PL - Polonia 6
CH - Svizzera 5
GR - Grecia 5
BR - Brasile 3
MX - Messico 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
IR - Iran 2
KR - Corea 2
NG - Nigeria 2
NO - Norvegia 2
RO - Romania 2
SI - Slovenia 2
CO - Colombia 1
DK - Danimarca 1
ET - Etiopia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
LY - Libia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
RU - Federazione Russa 1
TN - Tunisia 1
TR - Turchia 1
TW - Taiwan 1
Totale 25.761
Città #
Fairfield 3.474
Woodbridge 2.251
Houston 1.801
Ann Arbor 1.590
Ashburn 1.479
Chandler 1.398
Wilmington 1.287
Seattle 1.260
Cambridge 1.204
Jacksonville 1.105
Singapore 657
Princeton 500
Boardman 491
San Diego 360
Santa Clara 344
Beijing 292
Medford 241
Nanjing 203
Des Moines 183
Padova 177
Roxbury 177
Dong Ket 160
Helsinki 154
Guangzhou 60
Hebei 54
Shenyang 53
London 51
Norwalk 50
Nanchang 49
New York 47
Jiaxing 44
Dublin 40
Falls Church 40
Redwood City 34
Tianjin 33
Changsha 32
Hong Kong 23
Kharkiv 20
Jinan 19
Dallas 18
Milan 18
Shanghai 18
Ogden 16
Bergamo 13
Borås 13
Rome 13
Salerno 12
Hounslow 11
Kilburn 11
Indiana 10
Nürnberg 10
Rockville 10
Washington 10
Amsterdam 9
Detroit 9
Chicago 8
Dearborn 8
Ningbo 8
Origgio 8
Taizhou 8
Kunming 7
Los Angeles 7
Taiyuan 7
Tappahannock 7
Haikou 6
Munich 6
Sofia 6
Zhengzhou 6
A Coruña 5
Chiswick 5
Hirakata 5
Leeds 5
Marostica 5
Naples 5
Phoenix 5
Treviso 5
Acton 4
Boston 4
Hefei 4
Montecorvino Rovella 4
New Bedfont 4
Prescot 4
Pune 4
Redmond 4
Sahiwal 4
Tokyo 4
Venice 4
Verona 4
Vicenza 4
Aix-en-Provence 3
Baghdad 3
Brendola 3
Clifton 3
Cosenza 3
Council Bluffs 3
Florence 3
Fuzhou 3
Hangzhou 3
Hyderabad 3
Lappeenranta 3
Totale 21.855
Nome #
Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis 163
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. 144
Extrahepatic autoimmunity in autoimmune liver disease 144
The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report 140
Heparanase and macrophage interplay in the onset of liver fibrosis 140
Coronary flow reserve in patients with primary biliary cholangitis 140
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 138
Metabolic Syndrome Associated With Primary Biliary Cirrhosis. 137
Hepatitis C virus eradication with direct acting antiviral improves insulin resistance 137
Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis 134
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study 130
Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers. 126
Is osteopenia a peculiar association with primary biliary cirrhosis (PBC)? 126
Primary biliary cirrhosis: overlaps with other autoimmune disorders 126
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis 125
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis 125
Hepatitis A and hepatitis B virus infection in children and adolescents in north-east Italy. 123
Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers 122
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 122
Ursodeoxycholic Acid Therapy and Liver Transplant-free Survival in Patients with Primary Biliary Cholangitis 122
Acute hepatitis in elderly patients. 120
Is adiponectin a potential protective factor against atherosclerosis in primary biliary cirrhosis (PBC)? 120
Functional differentiation of human pluripotent stem cells on a chip 117
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. 117
Viral load in HCV RNA-positive pregnant women. 117
Effects of Age and Sex of on Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis 116
The administration of a high-fat diet alters bile acid composition and hepatic drug metabolism in rats 116
Preventative therapy in primary biliary cirrhosis 115
Hepatitis C virus infection in pregnancy. 114
Functional differentiation of human pluripotent stem cells on a chip. 112
Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment. 112
Colchicine in chronic hepatitis B: a pilot study 111
BRIC AUTOSOMAL DOMINANT BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS (BRIC) UNLINKED TO 18Q 21 LOCUS: IS IT A NEW ENTITY? 111
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. 111
Bone metabolism in male subjects undergoing liver transplantation (OLTx) 110
Are homes for the elderly still a risk area for HBV infection? 110
Plasma Adiponectin Levels in Primary Biliary Cirrhosis: A Novel Perspective for Link Between Hypercholesterolemia and Protection Against Atherosclerosis 110
A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis. 109
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region 109
A new non-invasive technique in primary sclerosing cholangitis (PSC): A case-control study 109
Intron 2 [IVS2, T-C +4] HFE gene mutation associated with S65C causes alternative RNA splicing and is responsible for iron overload 108
Familial primary biliary cirrhosis and autoimmune cholangitis 107
MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18–60 years of age) with chronic diseases who are at risk of post-influenza complications 107
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a Southern European population 107
Anti-hepatitis C virus in the elderly: a seroepidemiological study in a home for the aged. 107
Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis. 107
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 106
P.16.3 THE PROGNOSTIC ROLE OF MAGNETIC RESONANCE CHOLANGIOGRAPHY IN PSC 105
Primary biliary cirrhosis: report of a focus study group. 105
Liver transplantation and pregnancy. 105
Bone metabolism in orthotopic liver transplantation: a prospective study. 105
Gender medicine: a task for the third millennium. 105
In vitro metabolic zonation through oxygen gradient on a chip 105
Hepatitis C and pregnancy 104
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. 103
Type 1 autoimmune hepatitis: Clinical course and outcome in an Italian multicentre study 103
AISF position paper on liver disease and pregnancy 103
Primary biliary cholangitis: Old and novel therapy 103
Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. 102
Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal. 101
Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. 101
Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C 101
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 101
A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis. 101
Lack of increased frequency of the CC chemokine receptor 5-DELTA32/DELTA32 genotype in Hepatitis C 100
Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in earlyand late-stage cholestasis 100
Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment. 100
Y chromosome loss in male patients with primary biliary cirrhosis 99
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 99
HEPATOCELLULAR PROLIFERATION, TNF-ALPHA AND INFLAMMATION IN PRIMARY BILIARY-CIRRHOSIS (PBC) 98
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 98
An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy 97
Primary biliary cirrhosis and hepatitis C virus infection 97
The activation of NF-kB, Pregnane X Receptor, and Constitutive Androstane Receptor is modulated by the degree of cholestasis 97
Activation of the IGF1 system characterizes cholangiocyte survival duringprogression of primary biliary cirrhosis. 97
Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation 97
Bone metabolism in male subjects undergoing liver transplantation (OLTx) 97
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 97
Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). 96
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 96
THE EARLY DIAGNOSIS IMPROVES SURVIVAL IN PRIMARY BILIARY CIRRHOSIS: A 35-YEAR FOLLOW-UP IN A SINGLE CENTRE 96
Prevalence of familial disease in primary biliary cirrhosis in Italy 96
A new non-invasive technique in primary sclerosing cholangitis (PSC): A case-control study 95
Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C 95
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 95
New Insights on Intrahepatic Cholestasis of Pregnancy 94
null 93
Occupational risk of blood-borne viruses in healthcare workers: a 5-year surveillance program. 93
Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle 93
Etiopathogenesis of autoimmune hepatitis 93
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival 93
Response to influenza vaccine in people with non-protective HI antibody titers. 92
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 92
TTV infection in patients with acute hepatitis of defined aetiology and in acute non-A-E hepatitis 92
Morning bright light treatment for sleep-wake disturbances in primary biliary cholangitis: A pilot study 92
Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents. 92
Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations 91
New therapies for primary biliary cirrhosis 91
Intrafamilial transmission of hepatitis C virus infection 90
Cysteine and glutathione in the liver of patients with primary biliary cirrhosis. 90
Totale 10.855
Categoria #
all - tutte 97.489
article - articoli 89.286
book - libri 309
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.632
Totale 189.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.211 0 0 0 0 0 439 482 612 588 544 291 255
2020/20213.449 152 261 236 360 121 220 85 361 501 368 478 306
2021/20224.500 129 525 668 280 225 264 250 481 187 90 476 925
2022/20233.083 681 273 53 328 504 437 47 228 327 16 154 35
2023/20241.393 66 188 158 116 72 127 81 104 53 37 170 221
2024/20252.010 12 564 322 249 843 20 0 0 0 0 0 0
Totale 26.013